Thursday 12 November 2009

Solodyn


Solodyn is a brand name of minocycline, approved by the FDA in the following formulation(s):


SOLODYN (minocycline hydrochloride - tablet, extended release; oral)



  • Manufacturer: MEDICIS

    Approval date: May 8, 2006

    Strength(s): EQ 135MG BASE [RLD][AB], EQ 45MG BASE [AB], EQ 90MG BASE [AB]


  • Manufacturer: MEDICIS

    Approval date: July 23, 2009

    Strength(s): EQ 115MG BASE, EQ 65MG BASE


  • Manufacturer: MEDICIS

    Approval date: August 27, 2010

    Strength(s): EQ 105MG BASE, EQ 55MG BASE, EQ 80MG BASE

Has a generic version of Solodyn been approved?


A generic version of Solodyn has been approved by the FDA. However, this does not mean that the product will necessarily be commercially available - possibly because of drug patents and/or drug exclusivity. The following products are equivalent to Solodyn and have been approved by the FDA:


minocycline hydrochloride tablet, extended release; oral



  • Manufacturer: BARR

    Approval date: March 17, 2009

    Strength(s): EQ 135MG BASE [AB], EQ 45MG BASE [AB], EQ 90MG BASE [AB]


  • Manufacturer: IMPAX LABS INC

    Approval date: February 3, 2009

    Strength(s): EQ 135MG BASE [AB], EQ 45MG BASE [AB], EQ 90MG BASE [AB]


  • Manufacturer: LUPIN LTD

    Approval date: November 30, 2011

    Strength(s): EQ 135MG BASE [AB], EQ 45MG BASE [AB], EQ 90MG BASE [AB]


  • Manufacturer: MATRIX LABS LTD

    Approval date: July 20, 2010

    Strength(s): EQ 135MG BASE [AB], EQ 45MG BASE [AB], EQ 90MG BASE [AB]


  • Manufacturer: SANDOZ

    Approval date: August 13, 2009

    Strength(s): EQ 135MG BASE [AB], EQ 45MG BASE [AB], EQ 90MG BASE [AB]

Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Solodyn. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.

See also: About generic drugs.




Related Patents


Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.




  • Method for the treatment of acne
    Patent 5,908,838
    Issued: June 1, 1999
    Inventor(s): Gans; Eugene H.
    Assignee(s): Medics Pharmaceutical Corporation
    A method for the treatment of acne is provided which results in the reduction of vestibular side effects following administration of oral tetracycline antibiotics.
    Patent expiration dates:

    • February 19, 2018
      ✓ 
      Patent use: TREATMENT OF INFLAMMATORY LESIONS OF NON-NODULAR MODERATE TO SEVERE ACNE VULGARIS




  • Minocycline oral dosage forms for the treatment of acne
    Patent 7,541,347
    Issued: June 2, 2009
    Inventor(s): Wortzman; Mitchell & Plott; R. Todd & Bhatia; Kuljit & Patel; Bhiku
    Assignee(s): Medicis Pharmaceutical Coropration
    Minocycline oral dosage forms containing a controlled release carrier are useful for the treatment of acne.
    Patent expiration dates:

    • April 2, 2027
      ✓ 
      Patent use: TREATMENT OF INFLAMMATORY LESIONS OF NON-NODULAR MODERATE TO SEVERE ACNE VULGARIS




  • Minocycline oral dosage forms for the treatment of acne
    Patent 7,544,373
    Issued: June 9, 2009
    Inventor(s): Wortzman; Mitchell & Plott; R. Todd & Bhatia; Kuljit & Patel; Bhiku
    Assignee(s): Medicis Pharmaceutical Corporation
    Minocycline oral dosage forms containing a controlled release carrier are useful for the treatment of acne.
    Patent expiration dates:

    • April 2, 2027
      ✓ 
      Drug product




  • Minocycline oral dosage forms for the treatment of acne
    Patent 7,790,705
    Issued: September 7, 2010
    Inventor(s): Wortzman; Mitchell & Plott; R. Todd & Bhatia; Kuljit & Patel; Bhiku
    Assignee(s): Medicis Pharmaceutical Corporation
    Minocycline oral dosage forms containing a controlled release carrier are useful for the treatment of acne.
    Patent expiration dates:

    • June 24, 2025
      ✓ 
      Patent use: TREATMENT OF ACNE




  • Method for the treatment of acne
    Patent 7,919,483
    Issued: April 5, 2011
    Inventor(s): Wortzman; Mitchell & Plott; R. Todd & Bhatia; Kuljit & Patel; Bhiku
    Assignee(s): Medicis Pharmaceutical Corporation
    A method for treatment of acne with tetracyclines is provided. A lower sustained dose and no loading dose is employed, with an optional once-a-day dosing regimen.
    Patent expiration dates:

    • March 7, 2027
      ✓ 
      Patent use: TREATMENT OF ACNE



See also...

  • Solodyn Consumer Information (Drugs.com)
  • Solodyn Extended-Release Tablets Consumer Information (Wolters Kluwer)
  • Solodyn Consumer Information (Cerner Multum)
  • Minocycline Consumer Information (Drugs.com)
  • Minocycline Consumer Information (Wolters Kluwer)
  • Minocycline Capsules Consumer Information (Wolters Kluwer)
  • Minocycline Extended-Release Tablets Consumer Information (Wolters Kluwer)
  • Minocycline Injection Consumer Information (Wolters Kluwer)
  • Minocycline Pellet-Filled Capsules Consumer Information (Wolters Kluwer)
  • Minocycline Consumer Information (Cerner Multum)
  • Arestin eent AHFS DI Monographs (ASHP)
  • Minocycline Hydrochloride AHFS DI Monographs (ASHP)
  • Minocycline Hydrochloride eent AHFS DI Monographs (ASHP)
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)